Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Cancer Letters

• Publication date

  2021-08-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2021.08.023PMID 34428517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies

  2021cited by this paper
• The Complex Interplay between Antioxidants and ROS in Cancer.

  2020cited by this paper
• Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma

  2020cited by this paper
• Recent Progress in Ferroptosis Inducers for Cancer Therapy

  2019cited by this paper
• Targeting Autophagy in Cancer: Recent Advances and Future Directions.

  2019cited by this paper
• Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt‐regulated autophagy

  2019cited by this paper
• Targeting Metabolic-Redox Circuits for Cancer Therapy.

  2019cited by this paper
• Inhibition of base excision repair by natamycin suppresses prostate cancer cell proliferation.

  2019cited by this paper
• Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS/4E-BP1-Mediated Antitumor Effects.

  2019cited by this paper
• Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.

  2019cited by this paper
• MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling

  2019cited by this paper
• Silencing of Peroxiredoxin 1 Inhibits the Proliferation of Esophageal Cancer Cells and Promotes Apoptosis by Inhibiting the Activity of the PI3K/AKT Pathway

  2019cited by this paper
• ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin

  2019cited by this paper
• A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation.

  2018cited by this paper
• Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents

  2018cited by this paper
• Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2018cited by this paper
• Molecular therapies and precision medicine for hepatocellular carcinoma

  2018cited by this paper
• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cited by this paper
• Drug repurposing: progress, challenges and recommendations

  2018cited by this paper
• ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis

  2017cited by this paper
• Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells

  2017cited by this paper
• Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer

  2017cited by this paper
• ROS in Cancer: The Burning Question.

  2017cited by this paper
• New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.

  2017cited by this paper
• Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.

  2017cited by this paper
• Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer.

  2016cited by this paper
• Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro

  2016cited by this paper
• Transketolase counteracts oxidative stress to drive cancer development

  2016cited by this paper
• Identification and verification of PRDX1 as an inflammation marker for colorectal cancer progression.

  2016cited by this paper
• Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

  2016cited by this paper
• Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer.

  2015cited by this paper
• The role for autophagy in cancer.

  2015cited by this paper
• Metformin in cancer treatment and prevention.

  2015cited by this paper
• Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

  2014cited by this paper
• The four faces of autophagy: implications for cancer therapy.

  2014cited by this paper
• Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

  2013cited by this paper
• Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma

  2013cited by this paper
• ULK1 induces autophagy by phosphorylating Beclin-1 and activating Vps34 lipid kinase

  2013cited by this paper
• Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

  2011cited by this paper
• ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy

  2010cited by this paper
• Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma.

  2010cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• The DNA-damage response in human biology and disease

  2009cited by this paper
• ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.

  2009cited by this paper
• Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy

  2009cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Natamycin Blocks Fungal Growth by Binding Specifically to Ergosterol without Permeabilizing the Membrane*

  2008cited by this paper
• Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3

  2007cited by this paper
• ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

  2007cited by this paper
• How to Interpret LC3 Immunoblotting

  2007cited by this paper
• Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1

  2005cited by this paper
• Pimaricin potentiation of bleomycin activity against murine tumors.

  1983cited by this paper
• Prevention of surface mold growth on Italian dry sausage by natamycin and potassium sorbate

  1981cited by this paper

• Scoparone induces mitophagy and apoptosis via ROS accumulation in pancreatic cancer cells

  2026cites this paper
• OTUD7B attenuates renal fibrosis by regulating PRDX1 protein stability.

  2026cites this paper
• Redox guardian or oncogenic driver? The dual roles of PRDX1 in tumorigenesis.

  2025cites this paper
• Microbial infection and treatment strategies in cancer patients

  2025cites this paper
• Rapid Discovery of Celastrol Derivatives as Potent and Selective PRDX1 Inhibitors via Microplate-Based Parallel Compound Library and In Situ Screening.

  2025cites this paper
• Involvement of the PRDX family and its clinical functions in different types of gastrointestinal cancer (Review).

  2025cites this paper
• A new perspective on iron-dependent cell death: PRDX-1-mediated ferroptosis in tumor cells

  2025cites this paper
• A lactylation-ferroptosis cross-talk gene signature predicts hepatocellular carcinoma prognosis and reveals STMN1/PRDX1 as therapeutic targets

  2025cites this paper
• Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma

  2024cites this paper
• Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells.

  2024cites this paper
• The heterogeneous impacts of environmental technologies and research and development spending on green growth in emerging economies: the moderating role of financial globalization

  2024cites this paper
• PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer

  2024cites this paper
• Expression And Prognostic Role of PRDX1 In Gastrointestinal Cancers

  2023cites this paper
• Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches

  2023cites this paper
• Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells

  2023cites this paper
• UHRF2 promotes the malignancy of hepatocellular carcinoma by PARP1 mediated autophagy.

  2023cites this paper
• Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future.

  2023cites this paper
• Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survival

  2023cites this paper
• Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer

  2022cites this paper
• Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma

  2022cites this paper
• Artemether inhibits proliferation, invasion and migration of hepatocellular carcinoma cells via targeting of CYP2J2

  2022cites this paper
• Oxidative Stress in Intervertebral Disc Degeneration: New Insights from Bioinformatic Strategies

  2022cites this paper
• Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.

  2022cites this paper
• 20(S)-Protopanaxadiol from Panax ginseng Induces Apoptosis and Autophagy in Gastric Cancer Cells by Inhibiting Src.

  2022cites this paper
• Biological function and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges.

  2022cites this paper
• Repurposing antifungal drugs for cancer therapy

  2022influential citation
• Research Progress of DUB Enzyme in Hepatocellular Carcinoma

  2022cites this paper
• Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway

  2022cites this paper
• Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest

  2022cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper
• Kinome-wide synthetic lethal screen identi�es PANK4 as modulator of resistance in glioblastoma

  year unknowncites this paper